Insider filing · IONS
Holly B. Kordasiewicz sold $4.5M of Ionis Pharmaceuticals (IONS)
Executed Jun 12, disclosed Jun 16, 4 days later.
Value, as filed
$4.5M
60,846 sh across 2 lots
Executed
Jun 12
the trade date, as filed
Disclosed
Jun 16
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HK
Holly B. Kordasiewicz
EVP, Chief Development Officer
profile →
Holly B. Kordasiewicz (EVP, Chief Development Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $4.5M of IONS (60,846 sh across 2 lots, as filed), executed Jun 12.
The name
IONS
Ionis Pharmaceuticals, Inc.
IONS · Healthcare · 119 filings in 24 months
ticker →
Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Holly B. Kordasiewicz in IONS
IONSSALE
Ionis Pharmaceuticals, Inc.
$313K4,141 sh × $75.66
Exec Jan 16
Filed Jan 20 · 5:30 PM ET